BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11642499)

  • 1. Intensive immunosuppression and autologous stem cell transplantation for patients with severe rheumatoid arthritis: the Leiden experience.
    van Laar JM; Verburg RJ; Fibbe WE; Breedveld FC
    J Rheumatol Suppl; 2001 Oct; 64():25-7. PubMed ID: 11642499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with rheumatoid arthritis: results of an open study to assess feasibility, safety, and efficacy.
    Verburg RJ; Kruize AA; van den Hoogen FH; Fibbe WE; Petersen EJ; Preijers F; Sont JK; Barge RM; Bijlsma JW; van de Putte LB; Breedveld FC; van Laar JM
    Arthritis Rheum; 2001 Apr; 44(4):754-60. PubMed ID: 11315914
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autologous stem cell transplantation for rheumatoid arthritis--interim report of 6 patients.
    Bingham SJ; Snowden J; McGonagle D; Richards S; Isaacs J; Morgan G; Emery P
    J Rheumatol Suppl; 2001 Oct; 64():21-4. PubMed ID: 11642498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intensive immunoablation and autologous blood stem cell transplantation in patients with refractory rheumatoid arthritis: the University of Nebraska experience.
    Pavletic SZ; Odell JR; Pirruccello SJ; Ursick MM; Haire CE; Sharp JG; Kessinger A; Klassen LW
    J Rheumatol Suppl; 2001 Oct; 64():13-20. PubMed ID: 11642497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.
    Snowden JA; Passweg J; Moore JJ; Milliken S; Cannell P; Van Laar J; Verburg R; Szer J; Taylor K; Joske D; Rule S; Bingham SJ; Emery P; Burt RK; Lowenthal RM; Durez P; McKendry RJ; Pavletic SZ; Espigado I; Jantunen E; Kashyap A; Rabusin M; Brooks P; Bredeson C; Tyndall A
    J Rheumatol; 2004 Mar; 31(3):482-8. PubMed ID: 14994391
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis.
    Moore J; Brooks P; Milliken S; Biggs J; Ma D; Handel M; Cannell P; Will R; Rule S; Joske D; Langlands B; Taylor K; O'Callaghan J; Szer J; Wicks I; McColl G; Passeullo F; Snowden J
    Arthritis Rheum; 2002 Sep; 46(9):2301-9. PubMed ID: 12355477
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A phase I/II dose escalation study of intensified cyclophosphamide and autologous blood stem cell rescue in severe, active rheumatoid arthritis.
    Snowden JA; Biggs JC; Milliken ST; Fuller A; Brooks PM
    Arthritis Rheum; 1999 Nov; 42(11):2286-92. PubMed ID: 10555022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunological reconstitution after autologous hematopoietic stem cell transplantation in patients with systemic sclerosis: relationship between clinical benefits and intensity of immunosuppression.
    Bohgaki T; Atsumi T; Bohgaki M; Furusaki A; Kondo M; Sato-Matsumura KC; Abe R; Kataoka H; Horita T; Yasuda S; Amasaki Y; Nishio M; Sawada K; Shimizu H; Koike T
    J Rheumatol; 2009 Jun; 36(6):1240-8. PubMed ID: 19447934
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of severe systemic autoimmune diseases with autologous peripheral blood stem cell transplantation].
    Zhao Y; Zhou DB; Leng XM; Wang SJ; Li TS; Duan Y; Shen T; Zhao YQ; Zhang JP; Bai LJ; Cui W; Zhang FQ; Zeng XF; Zhang FC; Dong Y; Tang FL
    Zhonghua Yi Xue Za Zhi; 2004 Dec; 84(24):2077-81. PubMed ID: 15730620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Donor stem cell infusion after non-myeloablative conditioning for tolerance induction to HLA mismatched adult living-donor liver graft.
    Donckier V; Troisi R; Toungouz M; Colle I; Van Vlierberghe H; Jacquy C; Martiat P; Stordeur P; Zhou L; Boon N; Lambermont M; Schandené L; Van Laethem JL; Noens L; Gelin M; de Hemptinne B; Goldman M
    Transpl Immunol; 2004; 13(2):139-46. PubMed ID: 15380544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Autologous stem cell transplantation in children with severe progressive systemic or polyarticular juvenile idiopathic arthritis: long-term follow-up of a prospective clinical trial.
    Brinkman DM; de Kleer IM; ten Cate R; van Rossum MA; Bekkering WP; Fasth A; van Tol MJ; Kuis W; Wulffraat NM; Vossen JM
    Arthritis Rheum; 2007 Jul; 56(7):2410-21. PubMed ID: 17599770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intensive immunosuppression with autologous hematopoietic stem cell reconstitution as therapy for rheumatoid arthritis.
    Klassen LW
    J Rheumatol Suppl; 2001 Oct; 64():3-4. PubMed ID: 11642501
    [No Abstract]   [Full Text] [Related]  

  • 13. Considerations in the selection of an appropriate conditioning regimen for the treatment of rheumatoid arthritis by autologous peripheral blood stem cell transplantation.
    Kashyap A; Snowden J
    J Rheumatol Suppl; 2001 Oct; 64():39-41. PubMed ID: 11642503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autologous haematopoietic stem cell transplantation without CD34+ cell selection in refractory Crohn's disease.
    Cassinotti A; Annaloro C; Ardizzone S; Onida F; Della Volpe A; Clerici M; Usardi P; Greco S; Maconi G; Porro GB; Deliliers GL
    Gut; 2008 Feb; 57(2):211-7. PubMed ID: 17895357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High dose chemotherapy and syngeneic stem cell transplantation in a patient with refractory rheumatoid arthritis: poor response associated with persistence of host autoantibodies and synovial abnormalities.
    van Oosterhout M; Verburg RJ; Levarht EW; Moolenburgh JD; Barge RM; Fibbe WE; van Laar JM
    Ann Rheum Dis; 2005 Dec; 64(12):1783-5. PubMed ID: 16284342
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients.
    Burt RK; Traynor AE; Cohen B; Karlin KH; Davis FA; Stefoski D; Terry C; Lobeck L; Russell EJ; Goolsby C; Rosen S; Gordon LI; Keever-Taylor C; Brush M; Fishman M; Burns WH
    Bone Marrow Transplant; 1998 Mar; 21(6):537-41. PubMed ID: 9543056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of intensive immunosuppression and autologous stem cell transplantation in patients with severe rheumatoid arthritis is associated with the composition of synovial T cell infiltration.
    Verburg RJ; Flierman R; Sont JK; Ponchel F; van Dreunen L; Levarht EW; Welling MM; Toes RE; Isaacs JD; van Laar JM
    Ann Rheum Dis; 2005 Oct; 64(10):1397-405. PubMed ID: 15829573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of immune reconstitution after autologous CD34+ stem/progenitor cell transplantation for systemic sclerosis: predominant reconstitution of Th1 CD4+ T cells.
    Tsukamoto H; Nagafuji K; Horiuchi T; Mitoma H; Niiro H; Arinobu Y; Inoue Y; To K; Miyamoto T; Iwasaki H; Teshima T; Harada M; Akashi K
    Rheumatology (Oxford); 2011 May; 50(5):944-52. PubMed ID: 21172925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of relapse after autologous blood stem cell transplantation for severe rheumatoid arthritis.
    Pavletic SZ; Klassen LW; Pope R; O'Dell JR; Traynor AE; Haire CE; Graziano F; Oyama Y; Barr W; Burt RK
    J Rheumatol Suppl; 2001 Oct; 64():28-31. PubMed ID: 11642500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential for cytokine and product manipulation to improve the results of autologous stem cell transplantation for rheumatoid arthritis.
    Talmadge JE; Singh R; Ageitos A; Buyukberber S
    J Rheumatol Suppl; 2001 Oct; 64():32-8. PubMed ID: 11642502
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.